Rashid Deane, Ph.D. |
Small molecule therapeutics for neurodegenerative diseases, including Alzheimer's disease |
Neurosurgery |
Paul Dunman, Ph. D. |
High throughput screening for novel anti bacterial agents |
Microbiology & Immunology |
Rudi Fasan, Ph. D. |
Chemo-enzymatic synthesis of natural product derivatives with anticancer and antimalarial activity |
Chemistry |
Jonathan Friedberg, M.D. |
Kinase inhibitors for treatment of Iymphoma |
Medicine |
Harris Gelbard, M. D. |
Development of drugs for age-related and inflammatory diseases that target ancient caloric restriction pathways |
Neurology |
David Goldfarb, Ph.D. |
High throughput identification and development of novel lifespan extending compounds |
Biology |
Hartmut Land, Ph.D. |
Gene interactions in oncogenesis |
Biomedical Genetics |
Joe Miano, Ph.D. |
Small molecule inhibitors of genes that regulate pathologic blood vessel contraction |
Medicine |
Ben Miller, Ph.D. |
Chemical synthesis of small molecule ligands; novel RNA-directed therapies for HIV/AIDS |
Dermatology |
Harold Smith, Ph.D. |
Small molecule drugs targeting HIV-1 Vif and APOBEC3G |
Biochemistry & Biophysics |
Harry Stern, Ph.D. |
Small molecule docking and affinity calculations |
Chemistry |
Charles Thornton, M.D. |
Novel therapeutics targeting triplet repeat transcripts for treatment of myotonic muscular dystrophy |
Neurology |
Joseph Wedekind, Ph.D. |
Structural analysis of HIV-1 Vif and APOBEC3G |
Biochemistry & Biophysics |